|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| C07K 14/705 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3436079 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17776766.2 |
| Europos patento paraiškos padavimo data | 2017-03-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/025351 |
| Data | 2017-03-31 |
| (87) | Numeris | WO 2017/173256 |
| Data | 2017-10-05 |
| (30) | Numeris | Data | Šalis |
| 201662317258 P | 2016-04-01 | US |
| (72) |
WILTZIUS, Jed , US
|
| (73) |
Kite Pharma, Inc. ,
2400 Broadway, Santa Monica, CA 90404,
US
|
| (54) | CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE |
| CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE |